{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:17:13Z","timestamp":1788333433473,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deyang Municipal Bureau of Science and Technology","award":["2024SZY066"],"award-info":[{"award-number":["2024SZY066"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Primary intravascular large B-cell lymphoma (IVLBCL) is a rare and aggressive extranodal lymphoma that rarely affects the prostate. Its nonspecific clinical and laboratory features often lead to misdiagnosis as benign prostatic hyperplasia (BPH) or prostatitis, delaying appropriate treatment. We report a case of primary prostatic IVLBCL initially misdiagnosed as BPH, highlighting the diagnostic challenges and the importance of comprehensive pathological evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 75-year-old male presented with a 1-year history of a weakened urinary stream, dribbling, increased nocturia, and urinary urgency. Symptoms transiently improved with self-medication of the \u03b11-blocker tamsulosin but later recurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Histopathological examination revealed clusters of atypical tumor cells within the prostatic vasculature. Immunohistochemistry showed positivity for leukocyte common antigen, Vimentin, CD20, and CD79a, with a Ki-67 index\u2005&gt;\u200590%. A final diagnosis of primary intravascular large B-cell lymphoma of the prostate was established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Following diagnosis, the patient and his family declined any antitumor therapy (including chemotherapy) and opted for best supportive care and were discharged against medical advice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient died 5 months after diagnosis without receiving any subsequent antitumor therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Prostatic IVLBCL is a diagnostic mimic of BPH and requires a high index of suspicion. Immunohistochemistry and molecular studies are essential for accurate diagnosis. Early recognition and appropriate chemotherapy can improve outcomes in this rare malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049834","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:02:21Z","timestamp":1784322141000},"page":"e49834","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of primary prostate intravascular large B-cell lymphoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Fengju","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital, Deyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital, Deyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwu","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital, Deyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital, Deyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-4177","authenticated-orcid":false,"given":"Xianwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Deyang People\u2019s Hospital, Deyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1287363","article-title":"Intravascular large B-cell lymphoma in the United States (US): a population-based study using surveillance, epidemiology, and end results program and national cancer database.","volume":"58","author":"Rajyaguru","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"R2-20260902","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms.","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood-2017-04-737445","article-title":"Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks.","volume":"132","author":"Ponzoni","year":"2018","journal-title":"Blood"},{"key":"R4-20260902","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0046-8177(86)80648-7","article-title":"Angiotropic large cell lymphoma of the prostate gland: an immunohistochemical study.","volume":"17","author":"Ben-Ezra","year":"1986","journal-title":"Hum Pathol"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.2002.03725.x","article-title":"Intravascular lymphomatosis of the prostate gland.","volume":"119","author":"Chim","year":"2002","journal-title":"Br J Haematol"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1200\/JCO.2003.12.132","article-title":"Uncommon presentations of non-Hodgkin\u2019s lymphoma: case 1. Intravascular large B-cell lymphoma: diagnosis on prostate biopsy.","volume":"21","author":"Quintini","year":"2003","journal-title":"J Clin Oncol"},{"key":"R7-20260902","first-page":"1403","article-title":"Intravascular lymphoma treated with anti CD20 monoclonal antibodies. Report of one case.","volume":"132","author":"Alfaro","year":"2004","journal-title":"Rev Med Chil"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12253-008-9051-y","article-title":"Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.","volume":"14","author":"Csomor","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"R9-20260902","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1111\/j.1468-1331.2008.02382.x","article-title":"Intravascular lymphoma presenting with neurological signs but diagnosed by prostate biopsy: suspicion as a key to early diagnosis.","volume":"16","author":"Pusch","year":"2009","journal-title":"Eur J Neurol"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4274\/tjh.2013.0090","article-title":"Intravascular large B-cell lymphoma diagnosed on prostate biopsy: a case report.","volume":"31","author":"\u00d6zsan","year":"2014","journal-title":"Turk J Haematol"},{"key":"R11-20260902","doi-asserted-by":"crossref","first-page":"e18384","DOI":"10.1097\/MD.0000000000018384","article-title":"A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.","volume":"98","author":"Zhu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R12-20260902","first-page":"102276","article-title":"Prostate primary intravascular large B-cell lymphoma: a case report.","volume":"45","author":"Gu","year":"2022","journal-title":"Urol Case Rep"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4103\/IJPM.IJPM_324_20","article-title":"Intravascular large B cell lymphoma of prostate, a rare entity.","volume":"64","author":"Rallabandi","year":"2021","journal-title":"Indian J Pathol Microbiol"},{"key":"R14-20260902","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1066896911408721","article-title":"Prostate involvement by intravascular large B-cell lymphoma: a case report with literature review.","volume":"19","author":"Xu","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"R15-20260902","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1111\/cas.15091","article-title":"Current progress and future perspectives of research on intravascular large B-cell lymphoma.","volume":"112","author":"Shimada","year":"2021","journal-title":"Cancer Sci"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"43","DOI":"10.55729\/2000-9666.1008","article-title":"Intravascular large B cell lymphoma - still a diagnostic dilemma.","volume":"12","author":"Asif","year":"2022","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"R17-20260902","first-page":"e16459","article-title":"Intravascular large B-cell lymphoma: a diagnostic dilemma.","volume":"13","author":"Roy","year":"2021","journal-title":"Cureus"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bjh.15923","article-title":"Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States.","volume":"186","author":"Geer","year":"2019","journal-title":"Br J Haematol"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1002\/ctm2.131","article-title":"Serum interleukin-10 as a valuable biomarker for early diagnosis and therapeutic monitoring in intravascular large B-cell lymphoma.","volume":"10","author":"Zhang","year":"2020","journal-title":"Clin Transl Med"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2019.02.001","article-title":"The role of cytokines in the regulation of NK cells in the tumor environment.","volume":"117","author":"Konjevi\u0107","year":"2019","journal-title":"Cytokine"},{"key":"R21-20260902","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41391-025-01059-3","article-title":"Prostate biopsy: evolving strategies and perspectives.","volume":"29","author":"Franco","year":"2026","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.euo.2024.10.002","article-title":"Diagnostic effects of omitting systematic biopsies in prostate cancer screening.","volume":"8","author":"Chandra Engel","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"1350820","DOI":"10.1155\/2020\/1350820","article-title":"Prognostic value of concurrent expression of C-MYC and BCL2 in intravascular large B-cell lymphoma: a 10-year retrospective study.","volume":"2020","author":"Boonsakan","year":"2020","journal-title":"Biomed Res Int"},{"key":"R24-20260902","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/diagnostics11010010","article-title":"Histopathological ratios to predict gleason score agreement between biopsy and radical prostatectomy.","volume":"11","author":"Fiorentino","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"R25-20260902","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.2147\/CMAR.S267825","article-title":"Prognosis of Intravascular Large B Cell Lymphoma (IVLBCL): analysis of 182 patients from global case series.","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bjh.16081","article-title":"Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years.","volume":"187","author":"Matsue","year":"2019","journal-title":"Br J Haematol"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1470-2045(20)30059-0","article-title":"Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.","volume":"21","author":"Shimada","year":"2020","journal-title":"Lancet Oncol"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"20406207241270788","DOI":"10.1177\/20406207241270788","article-title":"Successful treatment of hemophagocytic intravascular large B-cell lymphoma with CNS involvement with BTK inhibitor combined with rituximab and high-dose methotrexate.","volume":"15","author":"Shao","year":"2024","journal-title":"Ther Adv Hematol"},{"key":"R29-20260902","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41409-019-0491-7","article-title":"Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: adult Lymphoma Working Group of the Japan society for hematopoietic cell transplantation.","volume":"54","author":"Kato","year":"2019","journal-title":"Bone Marrow Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:01:58Z","timestamp":1788332518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":29,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049834","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2025-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}